Viatris
VTRS
NZ$15.42
Share price
-0.76%
Change (1 day)
-23.52%
Change (1 year)
Categories
Viatris (VTRS) - P/B ratio
P/B ratio as of July 2025 : 0.6892
According to Viatris's latest financial reports the company has a price-to-book ratio of 0.752684.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Viatris - P/B ratio (from 2008 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 0.7993 | 25.92% |
| 2023-12-31 | 0.6348 | -0.89% |
| 2022-12-31 | 0.6405 | -19.78% |
| 2021-12-31 | 0.7985 | -18.96% |
| 2020-12-31 | 0.9853 | 12.87% |
| 2019-12-31 | 0.8730 | -24.84% |
| 2018-12-31 | 1.16 | -31.89% |
| 2017-12-31 | 1.71 | -7.12% |
| 2016-12-31 | 1.84 | -32.4% |
| 2015-12-31 | 2.72 | -57.93% |
| 2014-12-31 | 6.46 | 18.5% |
| 2013-12-31 | 5.45 | 68.55% |
| 2012-12-31 | 3.23 | 23.78% |
| 2011-12-31 | 2.61 | 2.46% |
| 2010-12-31 | 2.55 | 41.92% |
| 2009-12-31 | 1.80 | 62.85% |
| 2008-12-31 | 1.10 | -50.5% |
| 2007-12-31 | 2.23 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A | |
| 2002-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 3.48 | 404.28% | 🇺🇸 USA |
 OPKO Health
OPK | 0.8162 | 18.43% | 🇺🇸 USA |